Gestational diabetes: Diagnosis and management

Journal of Perinatology

Volumn 28, Issue 10, 2008, Pages 657-664

  Cheng, Y W ^a   Caughey, A B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLIBENCLAMIDE; GLUCOSE; INSULIN; INSULIN GLARGINE; INSULIN LISPRO; ISOPHANE INSULIN; METFORMIN; ORAL ANTIDIABETIC AGENT; OXYTOCIN;

BIRTH INJURY; BLOOD GLUCOSE MONITORING; BRACHIAL PLEXUS INJURY; CESAREAN SECTION; DIABETES CONTROL; DIET RESTRICTION; DIET THERAPY; DISEASE ASSOCIATION; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; EVENING DOSAGE; EXERCISE; GLUCOSE TOLERANCE TEST; HIGH RISK PREGNANCY; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; LABOR INDUCTION; MACROSOMIA; MATERNAL MORBIDITY; NEWBORN MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL COUNSELING; PATIENT COMPLIANCE; PATIENT EDUCATION; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; PRENATAL CARE; PUERPERIUM; REVIEW; RISK FACTOR; SHOULDER DYSTOCIA; SOCIAL STATUS; UNITED STATES; WEIGHT REDUCTION;

DIABETES, GESTATIONAL; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; PREDICTIVE VALUE OF TESTS; PREGNANCY; RISK FACTORS; UNITED STATES;

EID: 53949117983     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/jp.2008.62     Document Type: Review

References (72)

1. Engelgau MM, Herman WH, Smith PJ, German RR, Aubert RE. The epidemiology of diabetes and pregnancy in the U.S., 1988. Diabetes Care 1995; 18(7): 1029-1033.
2. Buchanan TA, Metzger BE, Freinkel N, Bergman RN. Insulin sensitivity and B-cell responsiveness to glucose during late pregnancy in lean and moderately obese women with normal glucose tolerance or mild gestational diabetes. Am J Obstet Gynecol 1990; 162(4): 1008-1014.
3. Ryan EA. Hormones and insulin resistance during pregnancy. Lancet 2003; 362(9398): 1777-1778.
4. Catalano PM, Hutson L, Amini SB, Kalhan SC. Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes mellitus. Am J Obstet Gynecol 1999; 180(4): 903-916.
5. Bowes SB, Hennessy TR, Umpleby AM, Benn JJ, Jackson NC, Boroujerdi MA et al. Measurement of glucose metabolism and insulin secretion during normal pregnancy and pregnancy complicated by gestational diabetes. Diabetologia 1996; 39(8): 976-983.
6. ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists. Number 30, September 2001 (replaces Technical Bulletin Number 200, December 1994). Gestational diabetes. Obstet Gynecol 2001; 98(3): 525-538.
7. Magee MS, Walden CE, Benefetti TJ, Knopp RH. Influence of diagnostic criteria on the incidence of gestational diabetes and perinatal morbidity. JAMA 1993; 269(5): 609-615.
8. American Diabetes Association. Gestational Diabetes Mellitus. Diabetes Care 2002; 25(Suppl 1): S94-S96.
9. Solomon CG, Willett WC, Carey VJ, Rich-Edwards J, Hunter DJ, Colditz GA et al. A prospective study of pregravid determinants of gestational diabetes mellitus. JAMA 1997; 278(13): 1078-1083.
10. Dooley SL, Metzger BE, Cho NH. Gestational diabetes mellitus. Influence of race on disease prevalence and perinatal outcome in a U.S. population. Diabetes 1991; 40(Suppl 2): 25-29.
11. Ramos GA, Caughey AB. The interrelationship between ethnicity and obesity on obstetric outcomes. Am J Obstet Gynecol 2005; 193 1089-1093.
12. Lipscomb KR, Gregory K, Shaw K. The outcome of macrosomic infants weighing at least 4500 g: Los Angeles County + University of Southern California experience. Obstet Gynecol 1995; 85(4): 558-564.
13. Lazer S, Biale Y, Mazor M, Lewenthal H, Insler V. Complications associated with the macrosomic fetus. J Reprod Med 1986; 31 (6): 501-505.
14. Rouse DJ, Owen J. Prophylactic cesarean delivery for fetal macrosomia diagnosed by means of ultrasonography-A Faustian bargain? Am J Obstet Gynecol 1999; 181(2): 332-338.
15. Bérard J, Dufour P, Vinatier D, Subtil D, Vanderstichèle S, Monnier JC et al. Fetal macrosomia: Risk factors and outcome. A study of the outcome concerning 100 cases > 4500 g. Eur J Obstet Gynecol Reprod Biol 1998; 77(1): 51-59.
16. Cohen BF, Penning S, Ansley D, Porto M, Garite T. The incidence and severity of shoulder dystocia correlates with a sonographic measurement of asymmetry in patients with diabetes. Am J perinatal 1999; 16 (4): 197-201.
17. Nesbitt TS, Gilbert WM, Herrchen B. Shoulder dystocia and associated risk factors with macrosomic infants born in California. Am J Obstet Gynecol 1998; 179(2): 476-480.
18. Casey BM, Lucas MJ, McIntire DD, Leveno KJ. Pregnancy outcomes in women with gestational diabetes compared with the general obstetric population. Obstet Gynecol 1997; 90(6); 869-873.
19. Jogev Y, Xenakis EM, Langer O. The association between preeclampsia and the severity of gestational diabetes: The impact of glycemic control. Am J Obstet Gynecol 2004; 191(5): 1655-1660.
20. Blank A, Grave G, Metzger BE. Effects of gestational diabetes on perinatal morbidity reassessed: Report of the Internal Workshop on Adverse Perinatal Outcomes of Gestational Diabetes Mellitus. December 3-4, 1992. Diabetes Care 1995; 18(1): 127-129.
21. Hod M, Merlob P, Friedman S, Schoenfeld A, Ovadia J. Gestational diabetes mellitus. A survey of perinatal complications in the 1980s. Diabetes 1991; 40(Suppl 2): 74-78.
22. Boney CM, Verma A, Tucker R, Vohr BR. Metabolic syndrome in childhood: Association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics 2005; 115(3): E290-e296.
23. Malcolm JC, Lawson ML, Gabourny I, Lough G, Keely E. Glucose tolerance of offspring of mother with gestational diabetes mellitus in a low-risk population. Diabet Med 2006; 23(5): 565-570.
24. Gillman MW, Rifas-Shiman S, Berkey CS, Field AE, Colditz GA. Maternal gestational diabetes, birth weight, and adolescent obesity. Pediatrics 2003; 111(3): E221-e226.
25. Silverman BL, Metzger BE, Cho NH, Loeb CA. Impaired glucose tolerance in adolescent offspring of diabetic mothers. Relationship to fetal hyperinsulinism. Diabetes Care 1995; 18(5): 611-617.
26. O'Sullivan JB, Mahan CM, Charles D, Dandrow RV. Screening criteria for high-risk gestational diabetic patients. Am J Obstet Gynecol 1973; 116(7): 895-900.
27. O'Sullivan JB, Mahan CM. Diagnostic capabilities of the intravenous glucose tolerance test. J Chronic Dis 1973; 26(3): 153-161.
28. O'Sullivan JB, Charles D, Mahan CM, Dandrow RV. Gestational diabetes and perinatal mortality rate. Am J Obstet Gynecol 1973; 116(7): 901-904.
29. Homko CJ, Reece EA. To screen or not to screen for gestational diabetes. The clinical quagmire. Clin Perinatol 2001; 28(2): 407-417.
30. Position Statement American Diabetes Association. Standards of Medical Care in Diabetes-2006. Diabetes Care 2006; 29: S4-S42.
31. Danilenko-Dixon DR, Van Winter JT, Nelson RL, Ogburn Jr PL. Universal versus selective gestational diabetes screening: Application of 1997 American Diabetes Association recommendations. Am J Obstet Gynecol 1999; 181(4): 798-802.
32. Nalyor CD, Sermer M, Chen E, Farine D. Selective screening for gestational diabetes mellitus. Toronto Trihospital Gestational Diabetes Project Investigators. N Engl J Med 1997; 337(22): 1591-1596.
33. U.S. Preventive Services Task Force. Screening for Gestational Diabetes Mellitus: Recommendations and Rationale. February 2003 www.ahrq.gov/ clinic/3rduspstf/gdm/gdmrr.htm.Accessed 25 January 2006.
34. Wilkins-Haug L, Horton JA, Cruess DF, Frigoletto FD. Antepartum screening in the office-based practice: Findings from the collaborative Ambulatory Research Network. Obstet Gynecol 1996; 88(4 Pt 1): 483-489.
35. Coustan DR, Nelson C, Carpenter MW, Carr SR, Rotondo L, Widness JA. Maternal age and screening for gestational diabetes: A population-based study. Obstet Gynecol 1989; 73(4): 557-561.
36. Esakoff TF, Cheng YW, Caughey AB. Screening for gestational diabetes: different cut-offs for different ethnicities? Am J Obstet Gynecol 2005; 193(3 Pt 2): 1040-1044.
37. Atilano LC, Lee-Parritz A, Lieberman E, Cohen AP, Barbieri RL. Alternative methods of diagnosing gestational diabetes mellitus. Am J Obstet Gynecol 1999; 181(5 Pt 1): 1158-1161.
38. Cheng JW, Esakoff TF, Block-Kurbisch I, Ustinov A, Shafer S, Caughey AB. Screening or diagnostic: Markedly elevated glucose loading tests and perinatal outcomes. J Matern Fetal Neonatal Med 2006; 19 (11): 729-734.
39. Alberti KG, Zimmet PZ. Definition, diagnosis, and classification of diabetes mellitus and its complications. Part 1: Diagnosis arid classification of diabetes mellitus provisional report of a WHO consultation. Diabetes Med 1998; 15(7): 539-553.
40. Schmidt MI, Duncan BB, Richelt AJ, Branchtein L, Matos MC, Costa e Forti A et al. Gestational diabetes mellitus diagnosed with a 2-h 75-g oral glucose tolerance test and adverse pregnancy outcomes. Diabetes Care 2001; 24(7): 1151-1155.
41. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2000; 23(suppl 1): S4-S19.
42. Metzger BE, Coustan DR. Summary and recommendation of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care 1998; 21(suppl 2): B161-B167.
43. Ferrara A, Weiss NS, Hedderson MM, Quesenberry Jr CP, Selby JV, Ergas IT et al. Pregnancy plasma glucose levels exceeding the American Diabetes Association thresholds, but below the National Diabetes Data Group thresholds for gestational diabetes mellitus, are related to the risk of neonatal macrosomia, hypoglycemia and hyperbilirubinaemia. Diabetologia 2007; 50(2): 298-306.
44. Jakobi P, Solt I, Weissman A. A 2 h versus the 3 h 100 g glucose tolerance test for diagnosing gestational diabetes mellitus. J Perinat Med 2004; 32(4): 320-322.
45. Stamilio DM, Olsen T, Ratcliffe S, Sehdev HM, Macones GA. False-positive 1-h glucose challenge test and adverse perinatal outcomes. Obstet Gynecol 2004; 103(1): 148-156.
46. McLaughlin GB, Cheng YW, Caughey AB. Women with one elevated 3-h glucose tolerance test value: Are they at risk for adverse perinatal outcomes? Am J Obstet Gynecol 2006; 194(5): 316-319.
47. Coustan DR, Carpenter MW. The diagnosis of gestational diabetes. Diabetes Care 1998; 21(Suppl 2): B5-B8.
48. Gabbe SG, Graves CR. Management of diabetes mellitus complicating pregnancy. Obstet Gynecol 2003; 102(4): 857-868.
49. Manderson JG, Patterson CC, Hadden DR, Traub AI, Ennis C, McCance DR. Preprandial versus postprandial blood glucose monitoring in type 1 diabetic pregnancy: A randomized controlled clinical trial. Am J Obstet Gynecol 2003; 189(2): 507-512.
50. De Veciana M, Major CA, Morgan MA, Asrat T, Toohey JS, Lien JM et al. Postparandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy. N Engl J Med 1995; 333(19): 1237-1241.
51. Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 2005; 352(24): 2477-2486.
52. Gonen O, Rosen DJ, Dolfin Z, Tepper R, Markov S, Fejgin MD. Induction of labor versus expectant management in macrosomia: A randomized study. Obstet Gynecol 1997; 89(6): 913-917.
53. Graves DE, White JC, Kirk JK. The use of insulin glargine with gestational diabetes mellitus. Diabetes Care 2006; 29(2): 471-472.
54. Elliott BD, Langer O, Schenker S, Johnson RF. Insignificant transfer of glyburide occurs across the human placenta. Am J Obstet Gynecol 1991; 165(3): 807-812.
55. Garcia-Bournissen F, Feig DS, Koren G. Maternal-fetal transport of hypoglycemic drugs. Clin Pharmacokinet 2003; 42(4): 303-313.
56. Langer O, Conway DL, Berkus MD, Xenakis EM, Gonzales O. A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med 2000; 343(16): 1134-1138.
57. Jacobson GF, Ramos GA, Ching JY, Kirby RS, Ferrara A, Field DR. Comparison of glyburide and insulin for the management of gestational diabetes in a large managed care organization. Am J Obstet Gynecol 2005; 193(1): 118-124.
58. Bertini AM, Silva JC, Taborda W, Becker F, Lemos Bebber FR, Zucco Viesi JM et al. Perinatal outcomes and the use of oral hypoglycemic agents. J Perinat Med 2005; 33(6): 519-523.
59. Chmait R, Dinise T, Moore T. Prospective observational study to establish predictors of glyburide success in women with gestational diabetes mellitus. J Perinatol 2004; 24(10): 617-622.
60. Kremer CJ, Duff P. Glyburide for the treatment of gestational diabetes. Am J Obstet Gynecol 2004; 190(5): 1438-1439.
61. Harborne L, Fleming R, Lyall H, Norman J, Sattar N. Descriptive review of the evidence for the use of metformin in polycystic ovary syndrome. Lancet 2003; 361(9372): 1894-1901.
62. Heard MJ, Pierce A, Carson SA, Buster JE. Pregnancies following use of metformin for ovulation induction in patients with polycystic ovary syndrome. Fertil Steril 2002; 77(4): 669-673.
63. Hofmann T, Horstmann G, Stammberger I. Evaluation of the reproductive toxicity and embryotoxicity of insulin glargine (LANTUS) in rats and rabbits. Intl J Toxicol 2002; 21(3): 181-189.
64. Kjos SL, Henry OA, Montoro M, Buchanan TA, Mestman JH. Insulin-requiring diabetes in pregnancy: A randomized trial of active induction of labor and expectant management. Am J Obstet Gynecol 1993; 169(3): 611-615.
65. O'Sullivan JB. Diabetes mellitus after GDM. Diabetes 1991; 40 (Suppl 2): 131-135.
66. Conway DL, Langer O. Effects of new criteria for type 2 diabetes on the rate of postpartum glucose intolerance in women with gestational diabetes. Am J Obstet Gynecol 1999; 181(3): 610-614.
67. Rouse DJ, Owen J, Goldenberg RL, Cliver SP. The effectiveness and costs of elective cesarean delivery for fetal macrosomia diagnosed by ultrasound. JAMA 1996; 276(18): 1480-1486.
68. Wiznitzer A, Furman B, Zuili I, Shany S, Reece EA, Mazor M. Cord leptin level and fetal macrosomia. Obstet Gynecol 2000; 96(5 Pt 1): 707-713.
69. American College of Obstetricians and Gynecologists: Fetal Macrosomia. ACOG Practice Bulletin, No. 22, Washington DC: American College of Obstetricians and Gynecologists, 2000.
70. Thipphawong J, Otulana B, Clauson P, Okikawa J, Farr JS. Pulmonary Insulin Administration Using the AERx® Insulin Diabetes System. Diabetes Technol Ther 2002; 4(4): 499-504.
71. Larson-Wadd K, Belani KG. Pancreas and islet cell transplantation. Anesthesiol Clin North America 2004; 22(4): 663-674.
72. Venstrom JM, McBride MA, Rother KI, Hirshberg B, Orchard TJ, Harlan DM. Survival after pancreas transplantation in patients with diabetes and preserved kidney function. JAMA 2003; 290(21): 2817-2823.